:@0.085519:0.075583:0.090751:0.075583:0.090751:0.059604:0.085519:0.059604:0.005232
 :@0.621674:0.075583:0.626906:0.075583:0.626906:0.059604:0.621674:0.059604:0.005232
 :@0.884977:0.940183:0.890322:0.940183:0.890322:0.922163:0.884977:0.922163:0.005345
Oral Presenter Abstract :@0.736982:0.075583:0.918858:0.075583:0.918858:0.059604:0.736982:0.059604:0.011658:0.006331:0.008492:0.004000:0.005293:0.010369:0.006331:0.008929:0.008569:0.008929:0.009573:0.005251:0.008929:0.006382:0.005321:0.010407:0.009403:0.008511:0.005289:0.006275:0.008531:0.008531:0.005340:0.005232
OT-7 :@0.083238:0.078822:0.144017:0.078822:0.144017:0.060055:0.083238:0.060055:0.018387:0.014681:0.007982:0.013113:0.006617
decreased  the  secretion  of  pro-:@0.085519:0.116012:0.371595:0.116012:0.371595:0.095949:0.085519:0.095949:0.010664:0.009759:0.009236:0.006689:0.009759:0.009045:0.009236:0.009759:0.010664:0.005951:0.005951:0.005189:0.010640:0.009759:0.005951:0.005927:0.009236:0.009759:0.009236:0.006665:0.009759:0.005070:0.004761:0.010664:0.010711:0.005951:0.005951:0.010664:0.005284:0.005951:0.005998:0.010664:0.006760:0.010869:0.007950
atherogenic  cytokines  (IFNγ,  TNFα,  IL:@0.371484:0.116012:0.711197:0.116012:0.711197:0.095949:0.371484:0.095949:0.009164:0.005094:0.010711:0.009664:0.006760:0.010664:0.010640:0.009759:0.010640:0.004761:0.009236:0.005951:0.005974:0.009236:0.009259:0.005189:0.010664:0.009093:0.004761:0.010640:0.009759:0.009188:0.005951:0.005998:0.006689:0.005332:0.010664:0.013139:0.009259:0.005213:0.005951:0.006022:0.010640:0.013020:0.010664:0.011235:0.005308:0.005951:0.005998:0.005332:0.010545
-6,  IL-:@0.711326:0.116012:0.770730:0.116012:0.770730:0.095949:0.711326:0.095949:0.007839:0.010664:0.005284:0.005951:0.005998:0.005332:0.010386:0.007950
1β).  GO  notably :@0.770762:0.116012:0.920505:0.116012:0.920505:0.095949:0.770762:0.095949:0.010664:0.011021:0.006546:0.005213:0.005951:0.006070:0.013163:0.013068:0.005951:0.005998:0.010711:0.010664:0.005189:0.009069:0.010664:0.004761:0.009093:0.005951
suppressed the expression of IL-:@0.085519:0.139428:0.357057:0.139428:0.357057:0.119365:0.085519:0.119365:0.009236:0.010687:0.010664:0.010664:0.006760:0.009688:0.009188:0.009188:0.009759:0.010497:0.004856:0.005189:0.010640:0.009759:0.004784:0.009759:0.009474:0.010664:0.006760:0.009664:0.009188:0.009188:0.004761:0.010664:0.010711:0.004665:0.010664:0.005213:0.004784:0.005332:0.010541:0.007950
1β, TNFα, CD36, ACAT1, and SRA1 genes, while enhancing ABCA1 :@0.357089:0.139428:0.920404:0.139428:0.920404:0.119365:0.357089:0.119365:0.010545:0.011021:0.005213:0.004856:0.010640:0.013020:0.010664:0.011140:0.005213:0.004903:0.013163:0.012925:0.010664:0.010664:0.005213:0.004665:0.011901:0.013044:0.011901:0.010735:0.010545:0.005213:0.004903:0.009164:0.010497:0.010664:0.004737:0.011901:0.012163:0.011901:0.010664:0.004689:0.010640:0.009759:0.010711:0.009664:0.009236:0.005141:0.004856:0.013377:0.010711:0.004761:0.004642:0.009759:0.004784:0.009759:0.010616:0.010711:0.009164:0.010616:0.009236:0.004761:0.010711:0.010640:0.004713:0.011901:0.011878:0.013163:0.011782:0.010545:0.005951
expression, which facilitates lipid efflux. rGO exhibited similar effects on gene expression, though it :@0.085519:0.162810:0.920392:0.162810:0.920392:0.142747:0.085519:0.142747:0.009759:0.009474:0.010664:0.006760:0.009664:0.009236:0.009236:0.004761:0.010664:0.010521:0.005141:0.006093:0.013377:0.010711:0.004761:0.009069:0.010711:0.006093:0.005213:0.009164:0.009236:0.004761:0.004761:0.004642:0.005189:0.009069:0.005189:0.009640:0.009236:0.006093:0.004761:0.004642:0.010664:0.004761:0.010664:0.005951:0.009759:0.005213:0.005284:0.004761:0.010687:0.009355:0.005213:0.006165:0.006760:0.013044:0.013139:0.006070:0.009545:0.009521:0.010711:0.004689:0.010664:0.004594:0.005189:0.009640:0.010664:0.006141:0.009236:0.004761:0.015900:0.004761:0.004642:0.009164:0.006665:0.006093:0.009759:0.005213:0.005213:0.009759:0.009236:0.005562:0.009236:0.005951:0.010664:0.010711:0.005998:0.010640:0.009759:0.010711:0.009664:0.006093:0.009759:0.009474:0.010664:0.006760:0.009664:0.009188:0.009188:0.004761:0.010664:0.010711:0.005094:0.006093:0.005189:0.010640:0.010664:0.010568:0.010640:0.010711:0.006141:0.004761:0.005070:0.005951
showed  increased  expression of IL-:@0.085519:0.186193:0.398106:0.186193:0.398106:0.166130:0.085519:0.166130:0.009236:0.010711:0.010664:0.013377:0.009759:0.010664:0.005951:0.003570:0.004761:0.010640:0.009236:0.006760:0.009664:0.009164:0.009188:0.009593:0.010664:0.005951:0.003594:0.009759:0.009474:0.010664:0.006760:0.009664:0.009188:0.009188:0.004761:0.010664:0.010711:0.009474:0.010545:0.005213:0.009450:0.005332:0.010649:0.007950
1β and SRA1 genes  in oxLDL:@0.398138:0.186193:0.663919:0.186193:0.663919:0.166130:0.398138:0.166130:0.010664:0.011021:0.009497:0.009164:0.010711:0.010664:0.009497:0.011901:0.012044:0.011901:0.010664:0.009474:0.010640:0.009759:0.010711:0.009664:0.009236:0.005951:0.003570:0.004761:0.010640:0.009521:0.010664:0.009545:0.010402:0.012972:0.010545
-treated  macrophages. These :@0.664149:0.186193:0.920464:0.186193:0.920464:0.166130:0.664149:0.166130:0.007982:0.005189:0.006641:0.009759:0.009045:0.005189:0.009640:0.010664:0.005951:0.003594:0.015995:0.009093:0.009236:0.006760:0.010783:0.010664:0.010711:0.009164:0.010640:0.009759:0.009188:0.005284:0.009378:0.010640:0.010711:0.009759:0.009188:0.009759:0.005951
results suggest that GO and rGO hold potential as therapeutic agents for reducing atherosclerosis :@0.085519:0.209474:0.919948:0.209474:0.919948:0.189411:0.085519:0.189411:0.006760:0.009640:0.009236:0.010687:0.004761:0.005070:0.009236:0.007379:0.009236:0.010545:0.010640:0.010711:0.009545:0.009236:0.005189:0.007331:0.004999:0.010711:0.009164:0.005070:0.007379:0.013163:0.013068:0.007379:0.009164:0.010711:0.010664:0.007355:0.006760:0.013044:0.013139:0.007212:0.010711:0.010664:0.004761:0.010664:0.007355:0.010545:0.010664:0.005189:0.009664:0.010711:0.005118:0.004761:0.009069:0.004761:0.007331:0.009164:0.009188:0.007426:0.005189:0.010640:0.009759:0.006641:0.009164:0.010664:0.009688:0.010687:0.005189:0.004642:0.009236:0.007426:0.009164:0.010640:0.009759:0.010640:0.005189:0.009188:0.007403:0.005141:0.010664:0.006760:0.007355:0.006760:0.009640:0.010664:0.010687:0.009236:0.004761:0.010545:0.010640:0.007284:0.009164:0.005094:0.010711:0.009664:0.006760:0.010664:0.009188:0.009236:0.004761:0.009759:0.006641:0.010664:0.009259:0.004761:0.009188:0.005951
risk by mitigating inflammation and preventing foam cell formation in macrophages. :@0.085519:0.232857:0.788258:0.232857:0.788258:0.212794:0.085519:0.212794:0.006760:0.004642:0.009236:0.009164:0.005951:0.010664:0.009259:0.005951:0.015995:0.004761:0.005070:0.004761:0.010640:0.009164:0.005094:0.004761:0.010640:0.010640:0.006022:0.004761:0.010640:0.005213:0.004761:0.009164:0.015995:0.015900:0.009164:0.005094:0.004761:0.010664:0.010711:0.005951:0.009164:0.010640:0.010664:0.005951:0.010735:0.006795:0.009759:0.009045:0.009759:0.010616:0.005189:0.004642:0.010711:0.010640:0.005951:0.005308:0.010664:0.008998:0.015995:0.005951:0.009236:0.009759:0.004665:0.004761:0.005951:0.005213:0.010664:0.006760:0.015995:0.009164:0.005070:0.004761:0.010664:0.010711:0.005951:0.004689:0.010711:0.005951:0.015995:0.009164:0.009236:0.006665:0.010664:0.010664:0.010711:0.009164:0.010640:0.009759:0.009093:0.005237:0.005951
 :@0.085519:0.256239:0.092136:0.256239:0.092136:0.237472:0.085519:0.237472:0.006617